Meglutol
Chemical compound
- C10AX05 (WHO)
- 3-hydroxy-3-methylpentanedioic acid
- 503-49-1
N
- 1662
- DB04377
Y
- 1600
Y
- CLA99KCD53
- D04897
Y
- CHEBI:16831
Y
- ChEMBL50444
Y
- DTXSID90198304
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- O=C(O)CC(O)(C)CC(=O)O
InChI
- InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)
Y
- Key:NPOAOTPXWNWTSH-UHFFFAOYSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Meglutol (INN, also known as 3-hydroxy-3-methylglutaric acid, β-hydroxy-β-methylglutaric acid, and dicrotalic acid) is a hypolipidemic agent.
It occurs free in Crotalaria dura and C. globifera and is bound in dicrotaline (pyrrolizidine alkaloid).
See also
- Crotalaria
- List of Crotalaria species
- Mevalonic acid
- v
- t
- e
Cholesterol absorption inhibitors, NPC1L1 | |
---|---|
Bile acid sequestrants/resins (LDL) |
Statins (HMG-CoA reductase, LDL) | |
---|---|
Niacin and derivatives (HDL and LDL) | |
MTTP inhibitors (VLDL) | |
ATP citrate lyase inhibitors (LDL) | |
Thyromimetics (VLDL) |
PPAR agonists (LDL) |
| ||||
---|---|---|---|---|---|
CETP inhibitors (HDL) | |||||
PCSK9 inhibitors (LDL) | |||||
ANGPTL3 inhibitors (LDL/HDL) |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e